MedPath

A CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHILODBHIDADI TAILA MATRA BASTI IN THE MANAGEMENT OF VATASHTHILA WITH SPECIAL REFERENCE TO BENIGN PROSTATIC HYPERPLASIA(BPH)

Phase 2
Not yet recruiting
Conditions
Benign prostatic hyperplasia withlower urinary tract symptoms,
Registration Number
CTRI/2020/03/024091
Lead Sponsor
PARUL INSTITUTE OF AYURVED
Brief Summary

NULL HYPOTHESIS  ;- *SHILODBHIDADI TAILA* IS NOT EFFECTIVE IN THE MANAGEMENT OF *VATASHTHILA*

ALTERNATE HYPOTHESIS :- *SHILODBHIDADI TAILA* IS EFFECTIVE IN THE MANAGEMENT OF *VATASHTHILA*

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
38
Inclusion Criteria

PATIENTS HAVING THE SIGNS AND SYMPTOMS OF VATASHTHILA (BPH).

Exclusion Criteria
  • PATIENTS BELOW 40 YRS OF AGE.
  • SUFFERING FROM UROGENITAL DEFORMITIES AND ANY PELVIC PATHOLOGY.
  • UNCONTROLLED HYPERTENSION AND DM.
  • TUBERCULOSIS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SHILODBHIDADI TAILA MATRABASTI WILL BE EFFECTIVE IN THE MANAGEMENT OF VATASHTHILASHILODBHIDADI TAILA MATRABASTI WILL BE EFFECTIVE IN THE MANAGEMENT OF VATASHTHILA WITHIN 4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

PARUL AYURVED HOSPITAL

🇮🇳

Vadodara, GUJARAT, India

PARUL AYURVED HOSPITAL
🇮🇳Vadodara, GUJARAT, India
DR MUKUND DHULE
Principal investigator
8379017299
drmukunddhule@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.